Page last updated: 2024-09-05

erlotinib hydrochloride and Dysarthosis

erlotinib hydrochloride has been researched along with Dysarthosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
García, N; Mezquita-Pérez, L; Pian, H	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Dysarthosis

Article	Year
Unusual progressive neurological syndrome in epidermal growth factor receptor-mutated lung adenocarcinoma, diagnosed at autopsy as invasive meningeal carcinomatosis. Archivos de bronconeumologia, 2016, Volume: 52, Issue:11 Topics: Adenocarcinoma; Coma; Dysarthria; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Genes, erbB-1; Humans; Lung Neoplasms; Meningeal Carcinomatosis; Mental Disorders; Middle Aged; Neoplasm Proteins; Protein Kinase Inhibitors; Sequence Deletion	2016

Article

Year

Unusual progressive neurological syndrome in epidermal growth factor receptor-mutated lung adenocarcinoma, diagnosed at autopsy as invasive meningeal carcinomatosis.

Archivos de bronconeumologia, 2016, Volume: 52, Issue:11

Topics: Adenocarcinoma; Coma; Dysarthria; ErbB Receptors; Erlotinib Hydrochloride; Fatal Outcome; Female; Genes, erbB-1; Humans; Lung Neoplasms; Meningeal Carcinomatosis; Mental Disorders; Middle Aged; Neoplasm Proteins; Protein Kinase Inhibitors; Sequence Deletion

2016